These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34448858)
1. Characterization of an Anti-Ebola Virus Hyperimmune Globulin Derived From Convalescent Plasma. Ciencewicki JM; Herbert AS; Storm N; Josleyn NM; Huie KE; McKay LGA; Griffiths A; Dye JM; Willis T; Arora V J Infect Dis; 2022 Feb; 225(4):733-740. PubMed ID: 34448858 [TBL] [Abstract][Full Text] [Related]
2. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States. Dean CL; Hooper JW; Dye JM; Zak SE; Koepsell SA; Corash L; Benjamin RJ; Kwilas S; Bonds S; Winkler AM; Kraft CS Transfusion; 2020 May; 60(5):1024-1031. PubMed ID: 32129478 [TBL] [Abstract][Full Text] [Related]
4. Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease. Brown JF; Dye JM; Tozay S; Jeh-Mulbah G; Wohl DA; Fischer WA; Cunningham CK; Rowe K; Zacharias P; van Hasselt J; Norwood DA; Thielman NM; Zak SE; Hoover DL J Infect Dis; 2018 Jul; 218(4):555-562. PubMed ID: 29659889 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model. Lee HN; McWilliams IL; Lewkowicz AP; Engel K; Ireland DDC; Kelley-Baker L; Thacker S; Piccardo P; Manangeeswaran M; Verthelyi D Emerg Microbes Infect; 2021 Dec; 10(1):2076-2089. PubMed ID: 34674613 [TBL] [Abstract][Full Text] [Related]
6. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle. Dye JM; Wu H; Hooper JW; Khurana S; Kuehne AI; Coyle EM; Ortiz RA; Fuentes S; Herbert AS; Golding H; Bakken RA; Brannan JM; Kwilas SA; Sullivan EJ; Luke TC; Smith G; Glenn G; Li W; Ye L; Yang C; Compans RW; Tripp RA; Jiao JA Sci Rep; 2016 Apr; 6():24897. PubMed ID: 27109916 [TBL] [Abstract][Full Text] [Related]
7. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis. Mellors J; Tipton T; Fehling SK; Akoi Bore J; Koundouno FR; Hall Y; Hudson J; Alexander F; Longet S; Taylor S; Gorringe A; Magassouba N; Konde MK; Hiscox J; Strecker T; Carroll M Front Immunol; 2022; 13():857481. PubMed ID: 35493467 [TBL] [Abstract][Full Text] [Related]
9. IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability. Zhang Y; Wei Y; Li Y; Wang X; Liu Y; Tian D; Jia X; Gong R; Liu W; Yang L PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008403. PubMed ID: 33711011 [TBL] [Abstract][Full Text] [Related]
10. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
11. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. Macneil A; Reed Z; Rollin PE PLoS Negl Trop Dis; 2011 Jun; 5(6):e1175. PubMed ID: 21666792 [TBL] [Abstract][Full Text] [Related]
12. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Wong G; Audet J; Fernando L; Fausther-Bovendo H; Alimonti JB; Kobinger GP; Qiu X Vaccine; 2014 Sep; 32(43):5722-9. PubMed ID: 25173474 [TBL] [Abstract][Full Text] [Related]
13. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses. Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247 [TBL] [Abstract][Full Text] [Related]